NASDAQ:ADMS
Delisted
Adamas Pharmaceuticals Stock News
$8.22
+0 (+0%)
At Close: May 27, 2022
Adamas Announces New Employment Inducement Grants
04:15pm, Friday, 08'th Oct 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company's board of directors granted eight new employees restric
Adamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awards
09:15am, Friday, 01'st Oct 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neu
Adamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society's (MDS) Congress
09:15am, Thursday, 16'th Sep 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neu
Adamas Announces New Employment Inducement Grants
05:00pm, Friday, 10'th Sep 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company's board of directors granted seven new employees restric
Adamas Announces New Employment Inducement Grant
04:16pm, Friday, 13'th Aug 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company's board of directors granted three new employees restric
Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q2 2021 Results - Earnings Call Transcript
09:50pm, Monday, 09'th Aug 2021
Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q2 2021 Results - Earnings Call Transcript
Adamas Pharmaceuticals (ADMS) Reports Q2 Loss, Lags Revenue Estimates
06:28pm, Monday, 09'th Aug 2021
Adamas (ADMS) delivered earnings and revenue surprises of 0.00% and -1.21%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Adamas Pharmaceuticals (ADMS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
04:44pm, Thursday, 29'th Jul 2021
Adamas (ADMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adamas Announces Issuance of New Patents for GOCOVRI and ADS-4101
09:15am, Thursday, 22'nd Jul 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neu
Adamas Announces New Employment Inducement Grant
04:05pm, Friday, 09'th Jul 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company's board of directors granted four new employees restrict
Adamas to Present at Upcoming William Blair Biotech Focus Conference
04:02pm, Thursday, 08'th Jul 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neu
Adamas Pharmaceuticals: Share Price Range-Bound Despite Steady Revenue Growth
08:17am, Tuesday, 06'th Jul 2021
Adamas Pharmaceuticals reported their Q1 earnings with a slight beat on EPS and a slight miss on revenue. GOCOVRI continues to report impressive growth despite a lackluster launch.
Implied Volatility Surging for Adamas Pharmaceuticals (ADMS) Stock Options
09:01am, Friday, 02'nd Jul 2021
Investors need to pay close attention to Adamas Pharmaceuticals (ADMS) stock based on the movements in the options market lately.
Adamas to Present at Upcoming SVB Leerink CNS Forum
04:42pm, Wednesday, 23'rd Jun 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neu
Adamas Announces New Employment Inducement Grant
04:08pm, Friday, 11'th Jun 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company's board of directors granted three new employees restric
